Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Vision Disorders HELP
Based on 19,542 articles published since 2010
||||

These are the 19542 published articles about Vision Disorders that originated from Worldwide during 2010-2020.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Practice Advisory for Perioperative Visual Loss Associated with Spine Surgery 2019: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Visual Loss, the North American Neuro-Ophthalmology Society, and the Society for Neuroscience in Anesthesiology and Critical Care. 2019

Anonymous1670972. · ·Anesthesiology · Pubmed #30531555.

ABSTRACT: -- No abstract --

2 Guideline None 2018

Martínez Rubioa, Ana / Cortés Rico, Olga / Pallás Alonso, Carmen Rosa / Rando Diego, Álvaro / Sánchez Ruiz-Cabello, Francisco Javier / Colomer Revuelta, Julia / Esparza Olcina, María Jesús / Gallego Iborra, Ana / García Aguado, Jaime / Sánchez-Ventura, José Galbe / Merino Moína, Manuel / Mengual Gil, José María. ·Especialista en Pediatría, Centro de Salud Camas, Sevilla. · Especialista en Pediatría, Centro de Salud Canillejas, Madrid. · Especialista en Pediatría, Hospital 12 de Octubre, Madrid. · Especialista en Pediatría, Centro de Salud Velilla de San Antonio, Mejorada del Campo, Madrid. · Especialista en Pediatría, Centro de Salud Zaidín Sur, Granada. · Especialista en Pediatría, Centro de Salud Fuente de San Luis, Valencia. · Especialista en Pediatría, Centro de Salud Barcelona, Móstoles, Madrid. · Especialista en Pediatría, Centro de Salud Trinidad-Jesús Cautivo, Málaga. · Especialista en Pediatría, Centro de Salud Villablanca, Madrid. · Especialista en Pediatría, Centro de Salud Torrero la Paz, Zaragoza. · Especialista en Pediatría, Centro de Salud el Greco, Getafe, Madrid. · Especialista en Pediatría. Centro de Salud Delicias-Sur, Zaragoza. ·Aten Primaria · Pubmed #29866354.

ABSTRACT: -- No abstract --

3 Guideline ACR Appropriateness Criteria 2018

Anonymous5300945 / Kennedy, Tabassum A / Corey, Amanda S / Policeni, Bruno / Agarwal, Vikas / Burns, Judah / Harvey, H Benjamin / Hoang, Jenny / Hunt, Christopher H / Juliano, Amy F / Mack, William / Moonis, Gul / Murad, Gregory J A / Pannell, Jeffrey S / Parsons, Matthew S / Powers, William J / Schroeder, Jason W / Setzen, Gavin / Whitehead, Matthew T / Bykowski, Julie. ·Principal Author, University of Wisconsin Hospital and Clinic, Madison, Wisconsin. Electronic address: tkennedy@uwhealth.org. · Panel Chair, Emory University, Atlanta, Georgia. · Panel Vice-Chair, University of Iowa Hospitals and Clinics, Iowa City, Iowa. · University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. · Montefiore Medical Center, Bronx, New York. · Massachusetts General Hospital, Boston, Massachusetts. · Duke University Medical Center, Durham, North Carolina. · Mayo Clinic, Rochester, Minnesota. · Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · University of Southern California, Los Angeles, California; neurosurgical consultant. · Columbia University Medical Center, New York, New York. · University of Florida, Gainesville, Florida; neurosurgical consultant. · University of California San Diego Medical Center, San Diego, California. · Mallinckrodt Institute of Radiology, Saint Louis, Missouri. · University of North Carolina School of Medicine, Chapel Hill, North Carolina; American Academy of Neurology. · Walter Reed National Military Medical Center, Bethesda, Maryland. · Albany ENT & Allergy Services, PC, Albany, New York; American Academy of Otolaryngology-Head and Neck Surgery. · Children's National Medical Center, Washington, District of Columbia. · Specialty Chair, UC San Diego Health, San Diego, California. ·J Am Coll Radiol · Pubmed #29724415.

ABSTRACT: Visual loss can be the result of an abnormality anywhere along the visual pathway including the globe, optic nerve, optic chiasm, optic tract, thalamus, optic radiations or primary visual cortex. Appropriate imaging analysis of visual loss is facilitated by a compartmental approach that establishes a differential diagnosis on the basis of suspected lesion location and specific clinical features. CT and MRI are the primary imaging modalities used to evaluate patients with visual loss and are often complementary in evaluating these patients. One modality may be preferred over the other depending on the specific clinical scenario. Depending on the pattern of visual loss and differential diagnosis, imaging coverage may require targeted evaluation of the orbits and/or assessment of the brain. Contrast is preferred when masses and inflammatory processes are differential considerations. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

4 Guideline Vision Screening in Children Aged 6 Months to 5 Years: US Preventive Services Task Force Recommendation Statement. 2017

Anonymous1620918 / Grossman, David C / Curry, Susan J / Owens, Douglas K / Barry, Michael J / Davidson, Karina W / Doubeni, Chyke A / Epling, John W / Kemper, Alex R / Krist, Alex H / Kurth, Ann E / Landefeld, C Seth / Mangione, Carol M / Phipps, Maureen G / Silverstein, Michael / Simon, Melissa A / Tseng, Chien-Wen. ·Kaiser Permanente Washington Health Research Institute, Seattle. · University of Iowa, Iowa City. · Veterans Affairs Palo Alto Health Care System, Palo Alto, California. · Stanford University, Stanford, California. · Harvard Medical School, Boston, Massachusetts. · Columbia University, New York, New York. · University of Pennsylvania, Philadelphia. · Virginia Tech Carilion School of Medicine, Roanoke. · Nationwide Children's Hospital, Columbus, Ohio. · Fairfax Family Practice Residency, Fairfax, Virginia. · Virginia Commonwealth University, Richmond. · Yale University, New Haven, Connecticut. · University of Alabama at Birmingham. · University of California, Los Angeles. · Brown University, Providence, Rhode Island. · Boston University, Boston, Massachusetts. · Northwestern University, Evanston, Illinois. · University of Hawaii, Honolulu. · Pacific Health Research and Education Institute, Honolulu, Hawaii. ·JAMA · Pubmed #28873168.

ABSTRACT: Importance: One of the most important causes of vision abnormalities in children is amblyopia (also known as "lazy eye"). Amblyopia is an alteration in the visual neural pathway in a child's developing brain that can lead to permanent vision loss in the affected eye. Among children younger than 6 years, 1% to 6% have amblyopia or its risk factors (strabismus, anisometropia, or both). Early identification of vision abnormalities could prevent the development of amblyopia. Subpopulation Considerations: Studies show that screening rates among children vary by race/ethnicity and family income. Data based on parent reports from 2009-2010 indicated identical screening rates among black non-Hispanic children and white non-Hispanic children (80.7%); however, Hispanic children were less likely than non-Hispanic children to report vision screening (69.8%). Children whose families earned 200% or more above the federal poverty level were more likely to report vision screening than families with lower incomes. Objective: To update the 2011 US Preventive Services Task Force (USPSTF) recommendation on screening for amblyopia and its risk factors in children. Evidence Review: The USPSTF reviewed the evidence on the accuracy of vision screening tests and the benefits and harms of vision screening and treatment. Surgical interventions were considered to be out of scope for this review. Findings: Treatment of amblyopia is associated with moderate improvements in visual acuity in children aged 3 to 5 years, which are likely to result in permanent improvements in vision throughout life. The USPSTF concluded that the benefits are moderate because untreated amblyopia results in permanent, uncorrectable vision loss, and the benefits of screening and treatment potentially can be experienced over a child's lifetime. The USPSTF found adequate evidence to bound the potential harms of treatment (ie, higher false-positive rates in low-prevalence populations) as small. Therefore, the USPSTF concluded with moderate certainty that the overall net benefit is moderate for children aged 3 to 5 years. Conclusions and Recommendations: The USPSTF recommends vision screening at least once in all children aged 3 to 5 years to detect amblyopia or its risk factors. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of vision screening in children younger than 3 years. (I statement).

5 Guideline Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease. 2017

Gale, R / Scanlon, P H / Evans, M / Ghanchi, F / Yang, Y / Silvestri, G / Freeman, M / Maisey, A / Napier, J. ·The Action on DMO group, UK. · The York Hospital, York, UK. · Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK. · University Hospital, Llandough, Cardiff, UK. · Bradford Teaching Hospitals, Bradford, UK. · The Royal Wolverhampton NHS Trust, Wolverhampton, UK. · Belfast Health & Social Care Trust, Belfast, UK. · Royal Hallamshire Hospital, Sheffield, UK. · Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, UK. · Bayer, Reading, UK. ·Eye (Lond) · Pubmed #28490797.

ABSTRACT: This paper identifies best practice recommendations for managing diabetes and sight-threatening diabetic eye disease. The authors provide an update for ophthalmologists and allied healthcare professionals on key aspects of diabetes management, supported by a review of the pertinent literature, and recommend practice principles for optimal patient management in treating visual impairment due to diabetic eye disease. In people with diabetes, early optimal glycaemic control reduces the long-term risk of both microvascular and macrovascular complications. The authors propose more can and should be done to maximise metabolic control, promote appropriate behavioural modifications and encourage timely treatment intensification when indicated to ameliorate diabetes-related complications. All people with diabetes should be screened for sight-threatening diabetic retinopathy promptly and regularly. It is shown that attitudes towards treatment adherence in diabetic macular oedema appear to mirror patients' views and health behaviours towards the management of their own diabetes. Awareness of diabetic macular oedema remains low among people with diabetes, who need access to education early in their disease about how to manage their diabetes to delay progression and possibly avoid eye-related complications. Ophthalmologists and allied healthcare professionals play a vital role in multidisciplinary diabetes management and establishment of dedicated diabetic macular oedema clinics is proposed. A broader understanding of the role of the diabetes specialist nurse may strengthen the case for comprehensive integrated care in ophthalmic practice. The recommendations are based on round table presentations and discussions held in London, UK, September 2016.

6 Guideline [Diagnostic approach of vision loss occurring in a white eye]. 2016

Lamalle, A / Andris, C / Rakic, J M. ·Service d'Ophtalmologie, CHU de Liège, Belgique. ·Rev Med Liege · Pubmed #28383866.

ABSTRACT: Vision loss is a major symptom in ophthalmology. We report a clinical observation of acute unilateral non ischemic optic neuropathy in a 55 year old patient to illustrate the diagnostic approach of vision loss occurring in a white eye. Several algorithms are proposed to facilitate the diagnostic approach.

7 Guideline Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Pretreatment Ophthalmology Evaluation in Patients With Suspected Nonfunctioning Pituitary Adenomas. 2016

Newman, Steven A / Turbin, Roger E / Bodach, Mary E / Tumialan, Luis M / Oyesiku, Nelson M / Litvack, Zachary / Zada, Gabriel / Patil, Chirag G / Aghi, Manish K. ·*Department of Ophthalmology, University of Virginia, Charlottesville, Virginia; ‡Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; §Guidelines Department, Congress of Neurological Surgeons, Schaumburg, Illinois; ¶Barrow Neurological Institute, Phoenix, Arizona; ∥Department of Neurosurgery, Emory University, Atlanta, Georgia; #Department of Neurosurgery, George Washington University, Washington, DC; **Department of Neurological Surgery, University of Southern California, Los Angeles, California; ‡‡Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California; §§Department of Neurosurgery, University of California, San Francisco, San Francisco, California. ·Neurosurgery · Pubmed #27635960.

ABSTRACT: BACKGROUND: Nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary tumors. Visual symptoms from NFPAs are common and include visual field defects, loss of central vision, and motility problems resulting in diplopia. OBJECTIVE: To create evidence-based guidelines in an attempt to formulate guidance for preoperative ophthalmologic evaluation of NFPA patients. METHODS: An extensive literature search was performed. Only clinical articles describing preoperative ophthalmologic evaluation of adult patients with NFPA were included. To ascertain the class of evidence for the posttreatment follow-up, the authors used the Clinical Assessment evidence-based classification. RESULTS: Six studies met the inclusion criteria with respect to the questions regarding the preoperative ophthalmologic evaluation of NFPA patients. Based on the studies located through the search, the authors formulated evidence-based recommendations as they pertain to the necessity of ophthalmologic evaluation before surgical treatment. CONCLUSION: Preoperative ophthalmologic evaluation is recommended. Such evaluation can provide prognostic factors for recovery and, when paired with postoperative evaluation, documents postoperative change. In addition to formal ophthalmologic examination, tests of value include automated static perimetry and optical coherence tomography. Older patients and patients with longer duration (>4 months) of vision loss should be counseled regarding the reduced chance of postoperative vision improvement. The full guidelines document for this chapter can be located at https://www.cns.org/guidelines/guidelines-management-patients-non-functioning-pituitary-adenomas/Chapter_4. ABBREVIATIONS: NFPA, nonfunctioning pituitary adenomaOCT, optical coherence tomography.

8 Guideline Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). 2016

Marmor, Michael F / Kellner, Ulrich / Lai, Timothy Y Y / Melles, Ronald B / Mieler, William F / Anonymous100862. ·Department of Ophthalmology and Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California. · Zentrum für Seltene Netzhauterkrankungen, AugenZentrum Siegburg, Siegburg, Germany. · Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong. · Department of Ophthalmology, Kaiser Permanente, Redwood City Medical Center, Redwood City, California. · Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois, Chicago, Illinois. ·Ophthalmology · Pubmed #26992838.

ABSTRACT: BACKGROUND: The American Academy of Ophthalmology recommendations on screening for chloroquine (CQ) and hydroxychloroquine (HCQ) retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools. PATTERN OF RETINOPATHY: Although the locus of toxic damage is parafoveal in many eyes, Asian patients often show an extramacular pattern of damage. DOSE: We recommend a maximum daily HCQ use of ≤5.0 mg/kg real weight, which correlates better with risk than ideal weight. There are no similar demographic data for CQ, but dose comparisons in older literature suggest using ≤2.3 mg/kg real weight. RISK OF TOXICITY: The risk of toxicity is dependent on daily dose and duration of use. At recommended doses, the risk of toxicity up to 5 years is under 1% and up to 10 years is under 2%, but it rises to almost 20% after 20 years. However, even after 20 years, a patient without toxicity has only a 4% risk of converting in the subsequent year. MAJOR RISK FACTORS: High dose and long duration of use are the most significant risks. Other major factors are concomitant renal disease, or use of tamoxifen. SCREENING SCHEDULE: A baseline fundus examination should be performed to rule out preexisting maculopathy. Begin annual screening after 5 years for patients on acceptable doses and without major risk factors. SCREENING TESTS: The primary screening tests are automated visual fields plus spectral-domain optical coherence tomography (SD OCT). These should look beyond the central macula in Asian patients. The multifocal electroretinogram (mfERG) can provide objective corroboration for visual fields, and fundus autofluorescence (FAF) can show damage topographically. Modern screening should detect retinopathy before it is visible in the fundus. TOXICITY: Retinopathy is not reversible, and there is no present therapy. Recognition at an early stage (before any RPE loss) is important to prevent central visual loss. However, questionable test results should be repeated or validated with additional procedures to avoid unnecessary cessation of valuable medication. COUNSELING: Patients (and prescribing physicians) should be informed about risk of toxicity, proper dose levels, and the importance of regular annual screening.

9 Guideline Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement. 2016

Anonymous1140860 / Siu, Albert L / Bibbins-Domingo, Kirsten / Grossman, David C / Baumann, Linda Ciofu / Davidson, Karina W / Ebell, Mark / García, Francisco A R / Gillman, Matthew / Herzstein, Jessica / Kemper, Alex R / Krist, Alex H / Kurth, Ann E / Owens, Douglas K / Phillips, William R / Phipps, Maureen G / Pignone, Michael P. ·Mount Sinai School of Medicine, New York2James J. Peters Veterans Affairs Medical Center, Bronx, New York. · University of California, San Francisco. · Group Health Research Institute, Seattle, Washington. · University of Wisconsin, Madison. · Columbia University, New York, New York. · University of Georgia, Athens. · Pima County Department of Health, Tucson, Arizona. · Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts. · Independent consultant, Washington, DC. · Duke University, Durham, North Carolina. · Fairfax Family Practice, Fairfax, Virginia13Virginia Commonwealth University, Richmond. · New York University, New York. · Veterans Affairs Palo Alto Health Care System, Palo Alto, California16Stanford University, Stanford, California. · University of Washington, Seattle. · Brown University, Providence, Rhode Island. · University of North Carolina, Chapel Hill. ·JAMA · Pubmed #26934260.

ABSTRACT: DESCRIPTION: Update of the US Preventive Services Task Force (USPSTF) recommendation on screening for impaired visual acuity in older adults. METHODS: The USPSTF reviewed the evidence on screening for visual acuity impairment associated with uncorrected refractive error, cataracts, and age-related macular degeneration among adults 65 years or older in the primary care setting; the benefits and harms of screening; the accuracy of screening; and the benefits and harms of treatment of early vision impairment due to uncorrected refractive error, cataracts, and age-related macular degeneration. POPULATION: This recommendation applies to asymptomatic adults 65 years or older who do not present to their primary care clinician with vision problems. RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for impaired visual acuity in older adults. (I statement).

10 Guideline Retinopathy of prematurity: New Zealand recommendations for case detection and treatment. 2015

Dai, Shuan / Austin, Nicola / Darlow, Brian / Anonymous4270844 / Anonymous4280844 / Anonymous4290844 / Anonymous4300844. ·Department of Ophthalmology, Auckland City Hospital and Starship Children's Hospital, Auckland, New Zealand. · Department of Paediatrics, University of Otago, Christchurch, New Zealand. · Christchurch Hospital, University of Otago, Christchurch, New Zealand. ·J Paediatr Child Health · Pubmed #26428420.

ABSTRACT: -- No abstract --

11 Guideline The prone position during surgery and its complications: a systematic review and evidence-based guidelines. 2015

Kwee, Melissa M / Ho, Yik-Hong / Rozen, Warren M. ·1 Department of Surgery, Monash University, Clayton 3168, Victoria, Australia. ·Int Surg · Pubmed #25692433.

ABSTRACT: Surgery in the prone position is often a necessity when access to posterior anatomic structures is required. However, many complications are known to be associated with this type of surgery, as physiologic changes occur with increased pressure to anterior structures. While several studies have discussed postoperative vision loss, much fewer studies with lower levels of evidence have addressed other complications. A systematic literature review was conducted using 2 different databases, and 53 papers were regarded as appropriate for inclusion. Qualitative and quantitative analysis was performed. Thirteen complications were identified. Postoperative vision loss and cardiovascular complications, including hypovolemia and cardiac arrest, had the most number of studies and highest level of evidence. Careful planning for optimal positioning, padding, timing, as well as increased vigilance are evidence-based recommendations where operative prone positioning is required.

12 Guideline Vision and eye health in children 36 to <72 months: proposed data system. 2015

Hartmann, E Eugenie / Block, Sandra S / Wallace, David K / Anonymous740817. ·*PhD †OD, MEd, FAAO ‡MD, MPH University of Alabama at Birmingham, School of Optometry, Birmingham, Alabama (EEH) · Illinois College of Optometry, Chicago, Illinois (SSB) · and Department of Ophthalmology, Duke University Eye Center and Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina (DKW). ·Optom Vis Sci · Pubmed #25562478.

ABSTRACT: PURPOSE: This article provides a rationale for developing an integrated data system for recording vision screening and eye care follow-up outcomes in preschool-aged children. The recommendations were developed by the National Expert Panel to the National Center for Children's Vision and Eye Health at Prevent Blindness and funded by the Maternal and Child Health Bureau of the Health Resources and Services Administration, US Department of Health and Human Services. Guidance is provided regarding specific elements to be included, as well as the characteristics and architecture of such a data system. Vision screening for preschool-aged children is endorsed by many organizations concerned with children's health issues. Currently, there is a lack of data on the proportion of children screened and no effective system to ensure that children who fail screenings access appropriate comprehensive eye examinations and follow-up care. RESULTS: The expansion of currently existing, or developing integrated health information systems, which would include child-level vision screening data, as well as referral records and follow-up diagnosis and treatment, is consistent with the proposed national approach to an integrated health information system (National Health Information Infrastructure). Development of an integrated vision data system will enhance eye health for young children at three different levels: (1) the child level, (2) the health care provider level, and (3) an epidemiological level. CONCLUSIONS: It is critical that the end users, the professionals who screen children and the professionals who provide eye care, be involved in the development and implementation of the proposed integrated data systems. As essential stakeholders invested in ensuring quality eye care for children, this community of professionals should find increasing need and opportunities at local, state, and national levels to contribute to cooperative guidance for data system development.

13 Guideline Vision screening for children 36 to <72 months: recommended practices. 2015

Cotter, Susan A / Cyert, Lynn A / Miller, Joseph M / Quinn, Graham E / Anonymous720817. ·*OD, MS, FAAO †PhD, OD, FAAO ‡MD, MPH §MD, MSCE Southern California College of Optometry at Marshall B. Ketchum University, Fullerton, California (SAC) · Northeastern State University Oklahoma College of Optometry, Tahlequah, Oklahoma (LAC) · University of Arizona College of Medicine, Tucson, Arizona (JMM) · and Department of Ophthalmology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania (GEQ). ·Optom Vis Sci · Pubmed #25562476.

ABSTRACT: PURPOSE: This article provides recommendations for screening children aged 36 to younger than 72 months for eye and visual system disorders. The recommendations were developed by the National Expert Panel to the National Center for Children's Vision and Eye Health, sponsored by Prevent Blindness, and funded by the Maternal and Child Health Bureau of the Health Resources and Services Administration, United States Department of Health and Human Services. The recommendations describe both best and acceptable practice standards. Targeted vision disorders for screening are primarily amblyopia, strabismus, significant refractive error, and associated risk factors. The recommended screening tests are intended for use by lay screeners, nurses, and other personnel who screen children in educational, community, public health, or primary health care settings. Characteristics of children who should be examined by an optometrist or ophthalmologist rather than undergo vision screening are also described. RESULTS: There are two current best practice vision screening methods for children aged 36 to younger than 72 months: (1) monocular visual acuity testing using single HOTV letters or LEA Symbols surrounded by crowding bars at a 5-ft (1.5 m) test distance, with the child responding by either matching or naming, or (2) instrument-based testing using the Retinomax autorefractor or the SureSight Vision Screener with the Vision in Preschoolers Study data software installed (version 2.24 or 2.25 set to minus cylinder form). Using the Plusoptix Photoscreener is acceptable practice, as is adding stereoacuity testing using the PASS (Preschool Assessment of Stereopsis with a Smile) stereotest as a supplemental procedure to visual acuity testing or autorefraction. CONCLUSIONS: The National Expert Panel recommends that children aged 36 to younger than 72 months be screened annually (best practice) or at least once (accepted minimum standard) using one of the best practice approaches. Technological updates will be maintained at http://nationalcenter.preventblindness.org.

14 Guideline Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement. 2013

Moyer, Virginia A / Anonymous3190778. · ·Ann Intern Med · Pubmed #24325017.

ABSTRACT: DESCRIPTION: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for glaucoma. METHODS: The USPSTF reviewed evidence on the benefits and harms of screening for glaucoma and of medical and surgical treatment of early glaucoma. Beneficial outcomes of interest included improved vision-related quality of life and reduced progression of early asymptomatic glaucoma to vision-related impairment. The USPSTF also considered evidence on the accuracy of glaucoma screening tests. POPULATION: This recommendation applies to adults who do not have vision symptoms and are seen in a primary care setting. RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement)

15 Guideline Development of a mild traumatic brain injury-specific vision screening protocol: a Delphi study. 2013

Goodrich, Gregory L / Martinsen, Gary L / Flyg, Heidi M / Kirby, Jennine / Asch, Steven M / Brahm, Karen D / Brand, John M / Cajamarca, Diana / Cantrell, Jenette L / Chong, Theresa / Dziadul, John A / Hetrick, Barbara J / Huang, Michael A / Ihrig, Carolyn / Ingalla, Shanida P / Meltzer, Bradley R / Rakoczy, Chrystyna M / Rone, Ashley / Schwartz, Elliot / Shea, Jane E / Anonymous4970774. ·VA Palo Alto Health Care System, 795 Willow Rd, Bldg T-365, Menlo Park, CA 94025. Gregory.Goodrich@va.gov. ·J Rehabil Res Dev · Pubmed #24203539.

ABSTRACT: Although traumatic brain injury (TBI) can happen to anyone at any time, the wars in Iraq and Afghanistan have brought it renewed attention. Fortunately, most cases of TBI from the recent conflicts are mild TBI (mTBI). Still, many physical, psychological, and social problems are associated with mTBI. Among the difficulties encountered are oculomotor and vision problems, many of which can impede daily activities such as reading. Therefore, correct diagnosis and treatment of these mTBI-related vision problems is an important part of patient recovery. Numerous eye care providers in the Department of Veterans Affairs, in military settings, and in civilian practices specialize and are proficient in examining patients who have a history of TBI. However, many do not have this level of experience working with and treating patients with mTBI. Recognizing this, we used a modified Delphi method to derive expert opinions from a panel of 16 optometrists concerning visual examination of the patient with mTBI. This process resulted in a clinical tool containing 17 history questions and 7 examination procedures. This tool provides a set of clinical guidelines that can be used as desired by any eye care provider either as a screening tool or adjunct to a full eye examination when seeing a patient with a history of mTBI. The goal of this process was to provide optimal and uniform vision care for the patient with mTBI.

16 Guideline Guidelines for automated preschool vision screening: a 10-year, evidence-based update. 2013

Donahue, Sean P / Arthur, Brian / Neely, Daniel E / Arnold, Robert W / Silbert, David / Ruben, James B / Anonymous4400748. ·Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN 37232-8808, USA. sean.donahue@vanderbilt.edu ·J AAPOS · Pubmed #23360915.

ABSTRACT: In 2003 the American Association for Pediatric Ophthalmology and Strabismus Vision Screening Committee proposed criteria for automated preschool vision screening. Recent literature from epidemiologic and natural history studies, randomized controlled trials of amblyopia treatment, and field studies of screening technologies have been reviewed for the purpose of updating these criteria. The prevalence of amblyopia risk factors (ARF) is greater than previously suspected; many young children with low-magnitude ARFs do not develop amblyopia, and those who do often respond to spectacles alone. High-magnitude ARFs increase the likelihood of amblyopia. Although depth increases with age, amblyopia remains treatable until 60 months, with decline in treatment effectiveness after age 5. US Preventive Services Task Force Preventative Services Task Force guidelines allow photoscreening for children older than 36 months of age. Some technologies directly detect amblyopia rather than ARFs. Age-based criteria for ARF detection using photoscreening is prudent: referral criteria for such instruments should produce high specificity for ARF detection in young children and high sensitivity to detect amblyopia in older children. Refractive screening for ARFs for children aged 12-30 months should detect astigmatism >2.0 D, hyperopia >4.5 D, and anisometropia >2.5 D; for children aged 31-48 months, astigmatism >2.0 D, hyperopia > 4.0 D, and anisometropia >2.0 D. For children >49 months of age original criteria should be used: astigmatism >1.5 D, anisometropia>1.5 D, and hyperopia >3.5 D. Visually significant media opacities and manifest (not intermittent) strabismus should be detected at all ages. Instruments that detect amblyopia should report results using amblyopia presence as the gold standard. These new American Association for Pediatric Ophthalmology and Strabismus Vision Screening Committee guidelines will improve reporting of results and comparison of technologies.

17 Guideline [Preventive activities among the elderly]. 2012

Herreros, Y Herreros / López-Torres Hidalgo, J D / de-Hoyos Alonso, M C / Díez, J M Baena / Gorroñogoitia Iturbe, A / Lesende, I Martín / Anonymous5800749. ·Grupo de Actividades Preventivas en los Mayores del PAPPS. ·Aten Primaria · Pubmed #23399508.

ABSTRACT: -- No abstract --

18 Guideline Concise guidance: diagnosis and management of giant cell arteritis. 2010

Dasgupta, Bhaskar / Anonymous4940672. ·Essex University Southend University Hospital, Westcliff-on-Sea, Essex. bhaskar.dasgupta@southend.nhs.uk ·Clin Med (Lond) · Pubmed #20849016.

ABSTRACT: Giant cell arteritis (GCA) or temporal arteritis (TA) with polymyalgia rheumatica (PMR) is among the most common reasons for long-term steroid prescription. GCA is a critically ischaemic disease, the most common form of vasculitis and should be treated as a medical emergency. Visual loss occurs in up to a fifth of patients, which may be preventable by prompt recognition and treatment. The British Society for Rheumatology (BSR) and the British Health Professionals in Rheumatology (BHPR) have recently published guidelines on the management of PMR. The purpose of this concise guidance is to draw attention to the full guidelines to encourage the prompt diagnosis and urgent management of GCA, with emphasis on the prevention of visual loss. They provide a framework for disease assessment, immediate treatment and referral to specialist care for management and monitoring of disease activity, complications and relapse.

19 Guideline Orbits, vision, and visual loss. 2010

Wippold, F J / Anonymous3490648. ·Neuroradiology Section, Mallinckrodt Institute of Radiology, 510 S Kingshighway Blvd, St. Louis, MO 63110-1076, USA. wippold@mir.wustl.edu ·AJNR Am J Neuroradiol · Pubmed #20075107.

ABSTRACT: -- No abstract --

20 Guideline The cost of visual impairment: purposes, perspectives, and guidance. 2010

Frick, Kevin D / Kymes, Steven M / Lee, Paul P / Matchar, David B / Pezzullo, M Lynne / Rein, David B / Taylor, Hugh R / Anonymous2640648. ·Department of Health Policy and Management, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland, USA. kfrick@jhsph.edu ·Invest Ophthalmol Vis Sci · Pubmed #20071669.

ABSTRACT: -- No abstract --

21 Editorial Eccentric Fixation and Inverse Occlusion: Renewing Our Interest? 2019

Zurevinsky, Jocelyn. ·Eye Care Centre, Saskatoon City Hospital, Saskatoon, Saskatchewan, Canada. ·J Binocul Vis Ocul Motil · Pubmed #31697193.

ABSTRACT: The use of inverse occlusion and pleoptics came into favor in Europe and then in North America in the late 1940's, and fell out of favor less than 25 years later. Introduced as a method of promoting foveal fixation, and improving binocularity and vision in cases of eccentric fixation, it did not outperform conventional occlusion prescribed at an earlier age.In this issue, Godts and Mathysen provide a case series of 11 contemporary patients treated with inverse occlusion after patching failure. In response, this article reviews the procedures and goals of inverse occlusion and pleoptics using the historic information available, in attempt to ascertain whether there is an indication for renewing their use.

22 Editorial A vision for universal eye health. 2019

The Lancet, ?. · ·Lancet · Pubmed #31631841.

ABSTRACT: -- No abstract --

23 Editorial Optical treatment of strabismic amblyopia. 2019

McGraw, Paul V / Barrett, Brendan T / Ledgeway, Tim. ·Visual Neuroscience Group, School of Psychology, University of Nottingham, Nottingham, UK. · School of Optometry and Vision Sciences, Faculty of Life Sciences, University of Bradford, Bradford, UK. ·Ophthalmic Physiol Opt · Pubmed #31506980.

ABSTRACT: -- No abstract --

24 Editorial Fear and uncertainty around Kashmir's future. 2019

The Lancet, ?. · ·Lancet · Pubmed #31423985.

ABSTRACT: -- No abstract --

25 Editorial Visual function and CVI in children (cerebral visual impairment): The importance of understanding and treating it. 2019

González Viejo, I / García-Ormaechea Romeo, I / Tejada Palacios, P / López López, C / Escudero Gómez, J / Harto Castaño, M. ·Junta de la Sociedad Española de Oftalmología Pediátrica (SEDOP); Hospital Universitario Miguel Servet, Zaragoza, España. Electronic address: igonzalezv@salud.aragon.es. · Junta de la Sociedad Española de Oftalmología Pediátrica (SEDOP). · Junta de la Sociedad Española de Oftalmología Pediátrica (SEDOP); Hospital Universitario 12 de Octubre, Madrid, España. · Junta de la Sociedad Española de Oftalmología Pediátrica (SEDOP); Hospital Regional Universitario Carlos Haya, Málaga, España. ·Arch Soc Esp Oftalmol · Pubmed #31101477.

ABSTRACT: -- No abstract --

Next